Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
US Department of Justice
Medtronic
Citi
AstraZeneca
Teva
Accenture
QuintilesIMS
Moodys

Generated: May 24, 2018

DrugPatentWatch Database Preview

VICOPROFEN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Vicoprofen patents expire, and when can generic versions of Vicoprofen launch?

Vicoprofen is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in VICOPROFEN is hydrocodone bitartrate; ibuprofen. There are twenty-three drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the hydrocodone bitartrate; ibuprofen profile page.

US Patents and Regulatory Information for VICOPROFEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie VICOPROFEN hydrocodone bitartrate; ibuprofen TABLET;ORAL 020716-001 Sep 23, 1997 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for VICOPROFEN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie VICOPROFEN hydrocodone bitartrate; ibuprofen TABLET;ORAL 020716-001 Sep 23, 1997 ➤ Sign Up ➤ Sign Up
Abbvie VICOPROFEN hydrocodone bitartrate; ibuprofen TABLET;ORAL 020716-001 Sep 23, 1997 ➤ Sign Up ➤ Sign Up
Abbvie VICOPROFEN hydrocodone bitartrate; ibuprofen TABLET;ORAL 020716-001 Sep 23, 1997 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for VICOPROFEN
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Tablets 2.5 mg/200 mg ➤ Subscribe 2006-02-24
➤ Subscribe Tablets 5 mg/200 mg ➤ Subscribe 2005-05-27

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
US Army
Deloitte
QuintilesIMS
Colorcon
Fuji
Healthtrust
Cipla
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.